Found: 4
Select item for more details and to access through your institution.
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.
- Published in:
- Cancer Communications, 2020, v. 40, n. 8, p. 355, doi. 10.1002/cac2.12069
- By:
- Publication type:
- Article
Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.01639
- By:
- Publication type:
- Article
The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -- CLEAP 004 study.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1310239
- By:
- Publication type:
- Article
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1116, doi. 10.3390/cancers11081116
- By:
- Publication type:
- Article